
Ponsegromab
CAS No. 2368950-15-4
Ponsegromab( —— )
Catalog No. M36709 CAS No. 2368950-15-4
Ponsegromab (PF 06946860) is a selective and effective humanized anti-GDF15 antibody inhibitor with anti-cachexic activity.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 451 | Get Quote |
![]() ![]() |
5MG | 662 | Get Quote |
![]() ![]() |
10MG | 1064 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePonsegromab
-
NoteResearch use only, not for human use.
-
Brief DescriptionPonsegromab (PF 06946860) is a selective and effective humanized anti-GDF15 antibody inhibitor with anti-cachexic activity.
-
DescriptionPonsegromab (PF 06946860) is a potent and selective humanized anti-GDF15 antibody inhibitor with anti-cachexia activity. Ponsegromab binds to GDF15 and prevents the binding of GDF15 to GFRAL, thereby blocking GDF15/GFRAL-mediated signaling. Ponsegromab can be used in the research of cancers.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorTGF-beta/Smad
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2368950-15-4
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. E.J. Roeland, et al. 1696TiP Phase Ib study to assess the effect of PF-06946860 on appetite following subcutaneous administration in patients with anorexia and advanced cancer. VOLUME 32, SUPPLEMENT 5, S1185, SEPTEMBER 01, 2021. Annals of oncology.
molnova catalog



related products
-
Cixiophiopogon A
Cixiophiopogon A is a natural product from Ophiopogon japonicus.
-
Orcinol 1-O-beta-D-a...
Orcinol 1-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside has antioxidative activity.
-
REBAUDIOSIDE B(P)(NE...
REBAUDIOSIDE B tastes about 150 times sweeter than sucrose and it is non-caloric.